Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02878928 · ClinicalTrials.gov registry record · NA
Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety
A NA study of Depression and Anxiety, sponsored by AltheaDx.
- Completed
- Registry status
- NA
- Development phase
- 579
- Enrollment target
- 17
- Study locations
NCT02878928: Completed NA study of Depression and Anxiety, sponsored by AltheaDx.
NCT02878928 is a NA study of Depression and Anxiety that has completed, run by AltheaDx. The registered enrollment target is 579 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (26% lower). The trial reports 17 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02878928, a NA study of Depression and Anxiety, has completed, sponsored by AltheaDx.
- COMPLETED
- Registry status
- NA
- Development phase
- 579 participants
- Enrollment target
- 17
- Study locations
Study Summary
A prospective, multi-center, randomized, subject and outcome evaluator blind , parallel-group study evaluating the effect of pharmacogenetic-guided versus standard of care treatment for subjects diagnosed with depression and/or anxiety disorders.
Conditions Studied
Interventions
- GENETIC IDgenetix Neuropsychiatric Test Panel
Study Locations (17)
California
- Adnab Research - Rolling Hills
- Artemis Clinical Research - San Diego
- Adnab Research - Torrance
- Collaborative Neuroscience Network - Torrance
Florida
- Innovative Clinical Research - Lauderhill
- Innova Clinical Trials - Miami
- APG Research - Orlando
Georgia
- iResearch Atlanta - Decatur
- Meridian Clinical Research - Savannah
New York
- United Medical Associates - Binghamton
- Richmond Behavioral Associates - Staten Island
Louisiana
- Medpharmics - Metairie
Nebraska
- Meridian Clinical Research - Norfolk
North Carolina
- Carolina Partners in Mental HealthCare - Raleigh
Pennsylvania
- Detweiler Family Medicine - Lansdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 579 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT02878928 record still lists
NCT02878928 is an interventional study that assigns participants to a tested intervention. The registered 579 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 679 other Depression trials with a reported enrollment target (26% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which IDgenetix Neuropsychiatric Test Panel is the first listed.
NCT02878928 lists 17 locations in 10 states (California, Florida, Georgia).
Frequently Asked Questions
What is clinical trial NCT02878928 about?
NCT02878928 is a clinical study titled "Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety". A prospective, multi-center, randomized, subject and outcome evaluator blind , parallel-group study evaluating the effect of pharmacogenetic-guided versus standard of care treatment for subjects diagnosed with depression and/or anxiety disorders.
What is the current status of trial NCT02878928?
This trial is currently completed. It is a NA study. The enrollment target is 579 participants. The study started on 2016-05. Estimated completion is 2016-12.
What conditions does trial NCT02878928 study?
This clinical trial studies the following conditions: Depression, Anxiety.
What interventions are being tested in trial NCT02878928?
The interventions under investigation include: IDgenetix Neuropsychiatric Test Panel (GENETIC).
Who is sponsoring clinical trial NCT02878928?
This trial is sponsored by AltheaDx, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02878928 being conducted?
This trial has 17 study locations across California, Florida, Georgia, Louisiana, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02878928's enrollment target sits among peer trials
579 70th of 679 higher than 610 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- NCT05143177 · 580 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- NCT05696353 · 580 participants · Phase 3
Teen Driving Translation Study (NIH)
- NCT06578104 · 580 participants
PULSED AF Post-Approval Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia